| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 89.42B | 87.64B | 75.34B | 62.08B | 49.59B | 47.68B |
| Gross Profit | 25.44B | 25.83B | 20.90B | 11.76B | 7.55B | 10.34B |
| EBITDA | 15.07B | 14.81B | 11.28B | 5.46B | 1.47B | 4.77B |
| Net Income | 11.56B | 11.31B | 8.48B | 3.90B | 722.00M | 3.35B |
Balance Sheet | ||||||
| Total Assets | 122.21B | 123.04B | 105.75B | 88.69B | 75.47B | 71.13B |
| Cash, Cash Equivalents and Short-Term Investments | 2.29B | 19.84B | 76.09B | 62.25B | 49.72B | 45.00B |
| Total Debt | 8.39B | 6.90B | 6.89B | 6.89B | 6.39B | 4.90B |
| Total Liabilities | 90.17B | 92.72B | 80.15B | 68.41B | 59.57B | 52.90B |
| Stockholders Equity | 32.04B | 30.32B | 25.59B | 20.28B | 15.89B | 18.23B |
Cash Flow | ||||||
| Free Cash Flow | 16.42B | 17.20B | 14.83B | 10.39B | 6.56B | 7.52B |
| Operating Cash Flow | 16.77B | 17.55B | 15.12B | 10.64B | 6.85B | 7.76B |
| Investing Cash Flow | -9.55B | -14.53B | -13.75B | -10.84B | -7.96B | -3.12B |
| Financing Cash Flow | -7.25B | -3.04B | -1.32B | 78.00M | 1.13B | -4.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $56.94B | 5.47 | 42.71% | 1.91% | 4.40% | 209.62% | |
82 Outperform | $65.07B | 9.17 | 24.14% | 1.49% | 4.12% | 83.05% | |
80 Outperform | $25.93B | 22.22 | 17.98% | 2.10% | 17.87% | 90.86% | |
78 Outperform | $128.12B | 13.86 | 15.65% | 1.22% | 8.26% | 35.89% | |
77 Outperform | $25.60B | 12.62 | 19.48% | 1.88% | 6.61% | 9.14% | |
74 Outperform | $119.20B | 10.30 | 35.45% | 2.20% | 13.89% | 32.56% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |